Old Dog, New Trick: A Tumor-Intrinsic Role for PD-1 in Chemoresistant Tumor Subclones

Clin Cancer Res. 2023 Feb 1;29(3):505-507. doi: 10.1158/1078-0432.CCR-22-3022.

Abstract

Programmed cell death protein 1 (PD-1) is a well-known driver of immunosuppression and lymphocyte-associated disease progression. Increasing evidence suggests a tumor-intrinsic role for PD-1 in promoting chemoresistance via stem-like features. Moving forward, a recent study implies a novel antitumor mechanism for PD-1 inhibition. See related article by Rotolo et al., p. 621.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Lung Neoplasms*
  • Lymphocytes / metabolism
  • Programmed Cell Death 1 Receptor* / antagonists & inhibitors

Substances

  • Programmed Cell Death 1 Receptor